ASRS 2023: Continuous Port Delivery System Cuts Treatment Burden for Diabetic Eye Conditions
The port delivery system with ranibizumab maintains similar vision outcomes to injection treatments
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.